Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE3
Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
- Status
- COMPLETED
- Phase
- PHASE3
CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
- Status
- UNKNOWN
- Phase
- PHASE4
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors
- Status
- UNKNOWN
- Phase
- PHASE4
Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
- Status
- UNKNOWN
- Phase
- PHASE3
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE2